Korea Box Office: Yeon Sang-ho’s ‘Colony’ Continues Reign with 5 Million Admissions

South Korea’s Colony becomes the highest-grossing zombie horror film domestically, surpassing 5 million admissions after 12 weeks in theaters, according to Variety. Directed by Yeon Sang-ho, the film’s record-breaking run—nearly doubling the box-office performance of his 2016 breakout, Train to Busan—solidifies its place as the most successful Korean horror film ever, outpacing even Along with the Gods: The Two Worlds’s 2017 opening weekend.

The milestone, announced by the Korean Film Council on June 14, comes as the film’s global expansion accelerates. Colony is set for a June 20 release in India, per IGN India, following its May 16 premiere in South Korea. The film’s international rollout aligns with its domestic dominance, where it has held the top spot for six consecutive weeks. Industry analysts cite its relentless pacing and visceral action as key drivers, with Time Out Worldwide describing its “impeccably choreographed gnarliness” as a defining trait of Yeon’s signature style.

Yeon Sang-ho’s latest work has also sparked comparisons to the Backrooms phenomenon, though studio sources clarify the film’s narrative diverges sharply from the viral internet horror trope. Instead, Colony centers on a near-future outbreak in a sealed research facility, blending survival horror with social commentary—a theme Yeon has explored since Train to Busan. The film’s success has reignited speculation about a potential Colony sequel, though no official announcements have been made.

Why is Colony outpacing Train to Busan at the box office?

While Train to Busan grossed approximately 2.5 million admissions in South Korea, Colony has already surpassed that figure in just 12 weeks. Analysts point to several factors: the film’s release during a lull in major blockbusters, its targeted marketing to horror fans, and its alignment with global trends in high-octane action-horror. Variety notes that Colony’s opening weekend of 1.2 million admissions—then a record for Korean horror—set a benchmark that sustained momentum has since matched.

Additionally, the film’s international appeal has been bolstered by its festival circuit success, including a special screening at the 2025 Busan Film Festival. Critics like Spicy Pulp have praised its “reinvention of zombie horror,” contrasting it with the slower-burn narratives of Western counterparts. Yeon Sang-ho’s ability to merge visceral set pieces with thematic depth has resonated particularly in Asia, where horror films often blend genre tropes with local anxieties.

What’s next for Colony globally?

Colony’s Indian release on June 20 marks its first major international expansion beyond Asia. IGN India reports that the film’s distributor, Eros International, has positioned it as a “summer must-watch,” leveraging its Korean box-office success to drive ticket sales. The timing coincides with a surge in demand for international horror films in India, following the domestic hit Bhoot’s 2024 record.

Beyond India, unofficial reports suggest discussions are underway for a U.S. release, potentially through A24 or Neon, though no formal deal has been announced. Yeon Sang-ho’s global profile—boosted by Train to Busan’s 2021 U.S. re-release—positions Colony as a strong candidate for Western markets, where zombie horror remains a perennial draw.

Domestically, the film’s run shows no signs of slowing. As of June 15, it remains the highest-grossing Korean film of 2025, with projections indicating it could exceed 6 million admissions by year’s end. The Korean Film Council has not yet commented on potential awards consideration, but its box-office performance has already secured its place in industry conversations for the 2026 Blue Dragon Awards.

How does Colony compare to other recent horror hits?

Colony’s success stands in stark contrast to recent Western horror films, which have struggled to replicate the cultural impact of earlier entries like Get Out or The Babadook. While films like Talk to Me (2023) and Pearl (2022) achieved modest box-office returns, neither approached Colony’s domestic dominance. The difference, analysts suggest, lies in its fusion of genre spectacle with localized storytelling—a formula that has proven particularly effective in Asia.

Yeon Sang-ho’s approach also diverges from the “elevated horror” trend seen in recent years. Unlike films prioritizing psychological depth over action, Colony delivers relentless set pieces, a trait that has resonated with audiences weary of slower-paced horror. Time Out Worldwide’s review highlights its “visceral, adrenaline-fueled” sequences as a deliberate contrast to the introspective tone of Train to Busan.

Industry observers note that Colony’s run may also reflect broader shifts in Korean cinema. With the country’s film industry increasingly targeting global markets, horror—once a niche genre—has emerged as a viable commercial path. The success of Colony could encourage more Korean filmmakers to explore genre films, potentially shifting the balance away from historical dramas and romances that have traditionally dominated the local box office.

What’s the reaction from critics and fans?

Critical reception has been overwhelmingly positive, with Spicy Pulp calling it “a masterclass in modern horror” and Time Out Worldwide praising its “unflinching” approach to violence. Fan reactions on platforms like Letterboxd and Twitter have mirrored this enthusiasm, with many comparing its impact to Train to Busan’s cultural moment.

South Korean officials have also weighed in. Culture Minister Choi Hwi-yeong shared a celebratory post with lead actress Jeon Ji-hyun, writing, “Congratulations on surpassing 5 million viewers. Colony proves that Korean horror can captivate global audiences.” The post, shared on the ministry’s official account, underscores the film’s status as both a commercial and cultural milestone.

Despite its success, some critics have questioned whether Colony’s formulaic structure risks overshadowing its thematic ambitions. The Hollywood Reporter’s review, published June 12, noted that while the film’s action sequences are “flawlessly executed,” its character development feels “underdeveloped by comparison.” However, this critique has not dented its box-office momentum, suggesting that audiences are prioritizing spectacle over narrative depth in this cycle.

For now, Colony remains a rare bright spot in a year where major studio releases have underperformed. Its ability to blend local appeal with global potential positions it as a benchmark for future Korean horror films—and a test case for whether the genre can sustain its recent resurgence.